Risk Prediction in Women With Congenital Long QT Syndrome
Ilan Goldenberg(Sheba Medical Center), Wojciech Zaręba(University of Rochester Medical Center), Arwa Younis(Cleveland Clinic), Mehmet K. Aktaş(University of Rochester Medical Center), David T. Huang(University of Rochester Medicine), Coeli M. Lopes(Icahn School of Medicine at Mount Sinai), Valentina Kutyifa, Katrina B. Sorensen(Mayo Clinic), Peter J. Kudenchuk(Public Health – Seattle & King County), Kaylie A. Briske(Mayo Clinic), Dan E. Arking(Johns Hopkins University), Michael J. Ackerman(Mayo Clinic), J. Martijn Bos(Mayo Clinic), Thomas D. Rea(Public Health – Seattle & King County), Spencer Rosero(University of Rochester Medicine), Anita Y. Chen(University of Rochester Medicine), Scott McNitt(University of Rochester), Christopher G. Scott(Mayo Clinic in Florida), Ayhan Yoruk(University of California San Francisco Medical Center), Nona Sotoodehnia(University of Washington)
Cited by 12
Related Papers
Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia
|Circulation|2010|2.7k
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk
|Nature|2011|2.1k
Genotype-Phenotype Correlation in the Long-QT Syndrome
|Circulation|2001|1.8k
Association between Microdeletion and Microduplication at 16p11.2 and Autism
|New England Journal of Medicine|2008|1.7k
Part 8: Adult Advanced Cardiovascular Life Support
|Circulation|2010|1.6k